Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ambu A/S: Extraordinary share option programme for the Executive Board related to the Big Five Strategy towards 2020

Ambu A/S
Posted on: 22 Dec 17

In accordance with the 'Overall guidelines for an incentive programme for the board of directors and executive board of Ambu A/S', the Board of Directors has decided to introduce a share option programme of up to 340,197 B-shares for the Executive Board (corresponding to 0.68% of the share capital), based on a price of DKK 2.5 each.


Lars Marcher, President & CEO, tel. +45 5136 2490, email:

Ambu A/S
Baltorpbakken 13
DK-2750 Ballerup
Tel. +45 7225 2000 
CVR no.: 63 64 49 19

Company Announcement no 12 2017_18

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire

Last updated on: 23/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.